We reflect on a year of life sciences innovation, highlighting Clarivate’s Drugs to Watch 2025, emerging therapy trends, AI-driven R&D and the evolving patent strategies shaping the sector.
The General Court overturned an EUIPO revocation, holding that proof of genuine use must be assessed holistically. It rejected excessive evidential burdens and confirmed sales via distributors can suffice.
An analysis of how the EPO Boards of Appeal and the UPC Munich Local Division assessed inventive step for Sanofi’s cabazitaxel patent and why they reached opposite outcomes in parallel proceedings
A UK court confirmed Dryrobe’s trade marks remain valid, ruling that rival D-ROBE infringed them. The case highlights the need for brand owners to prevent their marks from becoming generic.
With the Grinch leading major UK Christmas ads, brands are leveraging character merchandising and tight IP licensing to stand out in a £12bn festive advertising season.
WIPO’s updated Nice Classification, effective 1 Jan 2026, reclassifies eyewear, emergency vehicles, heated clothing and essential oils. Trademark owners should review portfolios and adjust filing strategies.
A look at the dispute between Sweaty Betty and Nixi Body over similar slogans and what it reveals about trade mark limits, descriptive branding and goodwill.
A guide to recording IP assignments worldwide, outlining key requirements, risks and best practices across the UK, EUIPO/EPC, Germany, Spain and the US to maintain ownership and enforce rights.
The CJEU clarifies that bad-faith trade mark filings face no time limits for invalidity actions, even when earlier owners knew of the bad faith or set deadlines in warning letters.
India has accepted its first smell trade mark for advertisement, a rose-scented tyre mark by Sumitomo. This milestone opens the door for broader protection of non-traditional trade marks.
